Five things to know:
1. Quarterly revenue rose 2.5% year over year, according to a news release.
2. Medtronic’s neuroscience portfolio, which includes cranial and spinal technologies, saw a 4.4% year-over-year increase in revenue with $2.5 billion.
3. Cranial and spinal technologies saw $1.25 billion in sales, a 3.8% increase year over year. Growth was driven by adoption of the AiBLE ecosystem of enabling technologies.
4. Neuromodulation sales were $476 million, a 12% year-over-year increase.
5. Medtronic expects its fiscal year 2025 revenue to grow between 4.75% to 5% year over year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
